SETD5SET domain containing 5
Autism Reports / Total Reports
16 / 43Rare Variants / Common Variants
134 / 0Chromosome Band
3p25.3Associated Disorders
DD/NDD, ADHD, ID, ASDGenetic Category
Rare Single Gene Mutation, Syndromic, FunctionalRelevance to Autism
Seven loss-of-function variants in the SETD5 gene, five of which were confirmed as de novo in origin, were identified in affected individuals following screening of 996 individuals with ID in Grozeva et al., 2014; two individuals with de novo LoF SETD5 variants were also identified as autistic in the supplementary material (PMID 24680889). A de novo LoF variant and a de novo likely damaging missense variant in the SETD5 gene were identified in two unrelated ASD probands from 2,270 trios screened by the Autism Sequencing Consortium in De Rubeis et al., 2014 (PMID 25363760); de novo missense variants in SETD5 had previously been observed in ASD probands from simplex families (Neale et al., 2012; Iossifov et al., 2012). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) in this report identified SETD5 as a gene meeting high statistical significance with a 0.05 < FDR 0.1, meaning that this gene had a 90% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). De novo LoF or damaging missense variants in SETD5 have also been identified in multiple individuals with developmental delay, intellectual disability, and/or epilepsy in the absence of ASD (PMIDs 23020937, 25138099, 27334371, 28191889, 28549204). Fernandes et al., 2018 reviewed a total of 42 individuals with SETD5 mutations from 17 publications and determined that ten of these individuals presented with autistic features (23.8%). Two de novo protein-truncating variants in SETD5 were identified in ASD probands from the Autism Sequencing Consortium in Satterstrom et al., 2020; additional protein-truncating variants in this gene were observed in case samples from the Danish iPSYCH study in this report. Furthermore, TADA analysis of de novo variants from the Simons Simplex Collection and the Autism Sequencing Consortium and protein-truncating variants from iPSYCH in Satterstrom et al., 2020 identified SETD5 as a candidate gene with a false discovery rate (FDR) 0.01. A two-stage analysis of rare de novo and inherited coding variants in 42,607 ASD cases, including 35,130 new cases from the SPARK cohort, in Zhou et al., 2022 identified SETD5 as a gene reaching exome-wide significance (P < 2.5E-06).
Molecular Function
This gene is predicted to encode a methyltransferase and resides within the critical interval for the 3p25 microdeletion syndrome.
External Links
SFARI Genomic Platforms
Reports related to SETD5 (43 Reports)
# | Type | Title | Author, Year | Autism Report | Associated Disorders |
---|---|---|---|---|---|
1 | Support | Patterns and rates of exonic de novo mutations in autism spectrum disorders | Neale BM , et al. (2012) | Yes | - |
2 | Support | De novo gene disruptions in children on the autistic spectrum | Iossifov I , et al. (2012) | Yes | - |
3 | Support | Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study | Rauch A , et al. (2012) | No | - |
4 | Support | Deletion of 3p25.3 in a patient with intellectual disability and dysmorphic features with further definition of a critical region | Kellogg G , et al. (2013) | No | - |
5 | Primary | De novo loss-of-function mutations in SETD5, encoding a methyltransferase in a 3p25 microdeletion syndrome critical region, cause intellectual disability | Grozeva D , et al. (2014) | No | OCD, ASD |
6 | Support | Convergence of genes and cellular pathways dysregulated in autism spectrum disorders | Pinto D , et al. (2014) | Yes | - |
7 | Support | Loss-of-function variants of SETD5 cause intellectual disability and the core phenotype of microdeletion 3p25.3 syndrome | Kuechler A , et al. (2014) | No | - |
8 | Recent Recommendation | Synaptic, transcriptional and chromatin genes disrupted in autism | De Rubeis S , et al. (2014) | Yes | - |
9 | Support | Large-scale discovery of novel genetic causes of developmental disorders | Deciphering Developmental Disorders Study (2014) | No | - |
10 | Recent Recommendation | Low load for disruptive mutations in autism genes and their biased transmission | Iossifov I , et al. (2015) | Yes | - |
11 | Support | Mutations in HECW2 are associated with intellectual disability and epilepsy | Halvardson J , et al. (2016) | No | - |
12 | Support | SETD5 loss-of-function mutation as a likely cause of a familial syndromic intellectual disability with variable phenotypic expression | Szczauba K , et al. (2016) | No | - |
13 | Support | Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases | Farwell Hagman KD , et al. (2016) | No | - |
14 | Support | De novo genic mutations among a Chinese autism spectrum disorder cohort | Wang T , et al. (2016) | Yes | - |
15 | Support | Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases | Stessman HA , et al. (2017) | No | - |
16 | Support | SETD5 gene variant associated with mild intellectual disability - a case report | Stur E , et al. (2017) | No | - |
17 | Recent Recommendation | Expansion and further delineation of the SETD5 phenotype leading to global developmental delay, variable dysmorphic features, and reduced penetrance | Powis Z , et al. (2017) | No | ADHD, ASD |
18 | Support | Expanding the genetic heterogeneity of intellectual disability | Anazi S , et al. (2017) | No | ADHD |
19 | Support | Exome sequencing reveals NAA15 and PUF60 as candidate genes associated with intellectual disability | Zhao JJ , et al. (2017) | No | Dysmorphic features, MCA |
20 | Support | Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands | Jin SC , et al. (2017) | No | Neurodevelopmental disorders (NDD) |
21 | Support | Exome Pool-Seq in neurodevelopmental disorders | Popp B , et al. (2017) | No | Hypotonia |
22 | Recent Recommendation | Genetic variations on SETD5 underlying autistic conditions | Fernandes IR , et al. (2018) | No | Autistic features |
23 | Recent Recommendation | Haploinsufficiency of the intellectual disability gene SETD5 disturbs developmental gene expression and cognition | Deliu E , et al. (2018) | No | - |
24 | Support | A novel mutation in a common pathogenic gene ( SETD5) associated with intellectual disability: A case report | Fang YL , et al. (2019) | No | DD, ID |
25 | Support | Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism | Satterstrom FK et al. (2020) | Yes | - |
26 | Support | SETD5 Gene Haploinsufficiency in Three Patients With Suspected KBG Syndrome | Crippa M et al. (2020) | No | ASD |
27 | Support | Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders | Wang T et al. (2020) | Yes | - |
28 | Support | - | Brunet T et al. (2021) | No | - |
29 | Support | - | Mahjani B et al. (2021) | Yes | - |
30 | Support | - | Hu C et al. (2022) | Yes | - |
31 | Support | - | Zhou X et al. (2022) | Yes | - |
32 | Support | - | Gabellini C et al. (2022) | Yes | - |
33 | Support | - | Spataro N et al. (2023) | No | ADHD, autistic features |
34 | Support | - | Zaghi M et al. (2023) | No | - |
35 | Support | - | Sanchis-Juan A et al. (2023) | No | - |
36 | Support | - | Sheth F et al. (2023) | Yes | DD, ID |
37 | Support | - | Karthika Ajit Valaparambil et al. () | Yes | - |
38 | Support | - | Erica Rosina et al. (2024) | No | - |
39 | Support | - | M Cecilia Poli et al. () | No | - |
40 | Support | - | Tamam Khalaf et al. (2024) | No | - |
41 | Support | - | Ruohao Wu et al. (2024) | Yes | - |
42 | Support | - | Laura E Burnett et al. () | Yes | - |
43 | Support | - | Axel Schmidt et al. (2024) | No | - |
Rare Variants (134)
Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Parental Transmission | Family Type | PubMed ID | Author, Year |
---|---|---|---|---|---|---|---|---|
- | - | copy_number_loss | De novo | - | - | 25138099 | Kuechler A , et al. (2014) | |
- | - | copy_number_loss | Unknown | - | - | 38438125 | Tamam Khalaf et al. (2024) | |
c.*3dup | - | frameshift_variant | De novo | - | - | 33004838 | Wang T et al. (2020) | |
- | - | copy_number_loss | De novo | - | Unknown | 24768552 | Pinto D , et al. (2014) | |
- | - | copy_number_loss | De novo | - | Simplex | 32793091 | Crippa M et al. (2020) | |
c.195T>A | p.Ser65%3D | stop_gained | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1782+1G>T | - | splice_site_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1576G>T | p.Glu526Ter | stop_gained | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.2021T>G | p.Leu674Ter | stop_gained | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.2205C>G | p.Thr735%3D | stop_gained | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.2644C>T | p.Arg882Ter | stop_gained | De novo | - | - | 33004838 | Wang T et al. (2020) | |
c.2644C>T | p.Arg882Ter | stop_gained | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.71+876dup | - | frameshift_variant | De novo | - | - | 28881385 | Powis Z , et al. (2017) | |
c.3520C>T | p.Arg1174Ter | stop_gained | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1333C>T | p.Arg445Ter | stop_gained | De novo | - | - | 28991257 | Jin SC , et al. (2017) | |
c.71+2260del | - | frameshift_variant | De novo | - | - | 28881385 | Powis Z , et al. (2017) | |
c.1783-2A>T | - | splice_site_variant | De novo | - | - | 28881385 | Powis Z , et al. (2017) | |
c.2347-7A>G | - | splice_site_variant | De novo | - | - | 28881385 | Powis Z , et al. (2017) | |
c.2476+1G>A | - | splice_site_variant | - | - | Simplex | 28940097 | Anazi S , et al. (2017) | |
c.598G>T | p.Glu200Ter | stop_gained | Unknown | - | - | 34615535 | Mahjani B et al. (2021) | |
c.814C>T | p.Gln272Ter | stop_gained | Unknown | - | - | 34615535 | Mahjani B et al. (2021) | |
c.3001C>T | p.Arg1001Ter | stop_gained | De novo | - | - | 28881385 | Powis Z , et al. (2017) | |
c.625C>T | p.Arg209Trp | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.554C>T | p.Thr185Met | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.977T>C | p.Leu326Pro | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.2347-7A>G | - | splice_region_variant | De novo | - | - | 36980980 | Spataro N et al. (2023) | |
c.1030G>A | p.Gly344Ser | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1591C>T | p.Arg531Trp | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1663G>A | p.Gly555Ser | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1763G>A | p.Arg588Gln | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.2237C>T | p.Pro746Leu | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.2269C>T | p.Arg757Cys | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.2300G>A | p.Arg767His | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.2348G>A | p.Arg783His | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.2416C>T | p.Gln806Ter | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.2698C>T | p.Arg900Cys | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.2932C>T | p.Arg978Trp | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.2933G>A | p.Arg978Gln | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.2509C>T | p.Arg837Cys | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.1783-2A>G | - | splice_site_variant | De novo | - | - | 39039281 | Axel Schmidt et al. (2024) | |
c.3407C>T | p.Ser1136Phe | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.3731G>A | p.Cys1244Tyr | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.3929C>T | p.Ser1310Leu | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.3235A>G | p.Lys1079Glu | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.4216T>A | p.Ser1406Thr | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.2983C>T | p.Arg995Ter | stop_gained | Unknown | - | - | 38438125 | Tamam Khalaf et al. (2024) | |
c.2302C>T | p.Arg768Ter | stop_gained | De novo | - | - | 39039281 | Axel Schmidt et al. (2024) | |
c.1967del | p.Leu656Ter | frameshift_variant | De novo | - | - | 33004838 | Wang T et al. (2020) | |
c.3556C>T | p.Arg1186Ter | stop_gained | De novo | - | - | 39039281 | Axel Schmidt et al. (2024) | |
c.2734C>T | p.Arg912Ter | stop_gained | Familial | Maternal | - | 33004838 | Wang T et al. (2020) | |
c.1524+1G>A | - | splice_site_variant | Familial | Paternal | - | 27824329 | Wang T , et al. (2016) | |
c.2302C>T | p.Arg768Ter | stop_gained | De novo | - | Simplex | 23020937 | Rauch A , et al. (2012) | |
c.2302C>T | p.Arg768Ter | stop_gained | De novo | - | Simplex | 28990276 | Zhao JJ , et al. (2017) | |
c.71+904A>G | - | intron_variant | De novo | - | Simplex | 31981491 | Satterstrom FK et al. (2020) | |
c.71+1947_71+1948insA | - | frameshift_variant | De novo | - | - | 28881385 | Powis Z , et al. (2017) | |
c.894A>G | p.Ile298Met | missense_variant | De novo | - | Simplex | 35982159 | Zhou X et al. (2022) | |
c.1195A>T | p.Lys399Ter | stop_gained | De novo | - | Simplex | 24680889 | Grozeva D , et al. (2014) | |
c.1043G>A | p.Arg348Gln | missense_variant | De novo | - | - | 28191889 | Stessman HA , et al. (2017) | |
c.2929T>A | p.Phe977Ile | missense_variant | Familial | Paternal | - | 35741772 | Hu C et al. (2022) | |
c.3001C>T | p.Arg1001Ter | stop_gained | De novo | - | Simplex | 24680889 | Grozeva D , et al. (2014) | |
c.922C>T | p.Arg308Ter | stop_gained | De novo | - | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.598G>T | p.Glu200Ter | stop_gained | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.922C>T | p.Arg308Ter | stop_gained | De novo | - | Simplex | 38041506 | Erica Rosina et al. (2024) | |
c.848G>A | p.Arg283Gln | missense_variant | Familial | Maternal | - | 33004838 | Wang T et al. (2020) | |
c.2949del | p.Met984CysfsTer7 | frameshift_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.4032_4033del | p.Ala1345Ter | frameshift_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1022G>A | p.Arg341His | missense_variant | Familial | Paternal | - | 33004838 | Wang T et al. (2020) | |
c.1125dup | p.Val376CysfsTer9 | frameshift_variant | De novo | - | - | 29158550 | Popp B , et al. (2017) | |
c.3737G>T | p.Ser1246Ile | missense_variant | Unknown | - | Simplex | 37543562 | Sheth F et al. (2023) | |
c.2158G>T | p.Glu720Ter | stop_gained | De novo | - | Simplex | 27334371 | Halvardson J , et al. (2016) | |
c.814C>T | p.Gln272Ter | stop_gained | De novo | - | Simplex | 31981491 | Satterstrom FK et al. (2020) | |
c.2476+2T>C | - | splice_site_variant | Unknown | - | Simplex | 37541188 | Sanchis-Juan A et al. (2023) | |
c.3929C>T | p.Ser1310Leu | missense_variant | Familial | Maternal | - | 33004838 | Wang T et al. (2020) | |
c.4106dup | p.Ser1370GlufsTer10 | frameshift_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1405G>A | p.Val469Ile | missense_variant | De novo | - | Simplex | 22495311 | Neale BM , et al. (2012) | |
c.547_567+60del | - | splice_site_variant | De novo | - | Simplex | 25138099 | Kuechler A , et al. (2014) | |
c.2438dup | p.Asn814GlufsTer2 | frameshift_variant | De novo | - | - | 36980980 | Spataro N et al. (2023) | |
c.3196-2A>G | - | splice_site_variant | Familial | Both parents | - | 38177409 | M Cecilia Poli et al. () | |
- | p.Thr552AsnfsTer5 | frameshift_variant | De novo | - | - | 27513193 | Farwell Hagman KD , et al. (2016) | |
c.3246del | p.Ala1083LeufsTer61 | frameshift_variant | De novo | - | - | 28881385 | Powis Z , et al. (2017) | |
c.2005G>A | p.Gly669Arg | missense_variant | De novo | - | Simplex | 22542183 | Iossifov I , et al. (2012) | |
c.367C>T | p.Arg123Trp | missense_variant | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.952T>C | p.Phe318Leu | missense_variant | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.1013_1014del | p.Val338GlyfsTer7 | frameshift_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1405G>A | p.Val469Ile | missense_variant | De novo | - | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.1022G>A | p.Arg341His | missense_variant | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.2164C>G | p.Pro722Ala | missense_variant | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.2307G>T | p.Arg769Ser | missense_variant | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.2348G>A | p.Arg783His | missense_variant | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.2351G>A | p.Trp784Ter | missense_variant | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.2920G>C | p.Asp974His | missense_variant | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.2942T>G | p.Phe981Cys | missense_variant | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.3066_3087dup | p.Glu1030ArgfsTer8 | frameshift_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.3773G>C | p.Ser1258Thr | missense_variant | De novo | - | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.3305G>A | p.Gly1102Asp | missense_variant | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.3527G>A | p.Arg1176Gln | missense_variant | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.3635C>T | p.Pro1212Leu | missense_variant | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.3907G>A | p.Ala1303Thr | missense_variant | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.71+1186_71+1201del | - | frameshift_variant | Unknown | - | Not simplex | 28940097 | Anazi S , et al. (2017) | |
c.3106C>T | XP_005265353.1:p.Arg1036Trp | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.3107G>A | XP_005265353.1:p.Arg1036Gln | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1282C>T | p.Pro428Ser | missense_variant | Unknown | - | - | 37943464 | Karthika Ajit Valaparambil et al. () | |
c.959del | p.Lys320AsnfsTer15 | frameshift_variant | De novo | - | Simplex | 32793091 | Crippa M et al. (2020) | |
c.3855dup | p.Ser1286LeufsTer37 | frameshift_variant | De novo | - | Simplex | 28549204 | Stur E , et al. (2017) | |
c.2154del | p.Val719LeufsTer18 | frameshift_variant | De novo | - | Unknown | 33619735 | Brunet T et al. (2021) | |
c.1866C>G | p.Tyr622Ter | stop_gained | Unknown | Not maternal | Simplex | 24680889 | Grozeva D , et al. (2014) | |
c.2918C>G | p.Ser973Ter | stop_gained | Familial | Paternal | Multiplex | 27375234 | Szczauba K , et al. (2016) | |
c.31A>G | p.Thr11Ala | missense_variant | Familial | Paternal | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.3855dup | p.Ser1286LeufsTer37 | frameshift_variant | De novo | - | Simplex | 38764027 | Ruohao Wu et al. (2024) | |
c.1333C>T | p.Arg445Ter | stop_gained | Unknown | Not maternal | Multiplex | 24680889 | Grozeva D , et al. (2014) | |
c.1374A>T | p.Ser458= | missense_variant | Familial | Paternal | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.71+1947_71+1948insA | - | frameshift_variant | Familial | Maternal | Simplex | 28881385 | Powis Z , et al. (2017) | |
c.3771dup | p.Ser1258GlufsTer65 | frameshift_variant | De novo | - | Simplex | 24680889 | Grozeva D , et al. (2014) | |
c.3856del | p.Ser1286LeufsTer84 | frameshift_variant | De novo | - | Simplex | 24680889 | Grozeva D , et al. (2014) | |
c.2025_2026del | p.Gly676ValfsTer2 | frameshift_variant | De novo | - | Simplex | 31656537 | Fang YL , et al. (2019) | |
c.1550C>T | p.Ala517Val | missense_variant | Familial | Maternal | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.1712G>C | p.Gly571Ala | missense_variant | Familial | Paternal | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.2006G>C | p.Gly669Ala | missense_variant | Familial | Maternal | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.2006G>C | p.Gly669Ala | missense_variant | Familial | Paternal | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.2348G>A | p.Arg783His | missense_variant | Familial | Maternal | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.2348G>A | p.Arg783His | missense_variant | Familial | Paternal | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.2468A>G | p.Asp823Gly | missense_variant | Familial | Maternal | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.2653T>C | p.Tyr885His | missense_variant | Familial | Maternal | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.1573_1574del | p.Leu525ArgfsTer17 | frameshift_variant | De novo | - | Simplex | 32793091 | Crippa M et al. (2020) | |
c.3174G>C | p.Gln1058His | missense_variant | Familial | Maternal | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.3817A>C | p.Ser1273Arg | missense_variant | Familial | Maternal | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.4081G>T | p.Val1361Phe | missense_variant | Familial | Paternal | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.2955T>A | p.Tyr985Ter | stop_gained | Familial | Maternal | Multi-generational | 28881385 | Powis Z , et al. (2017) | |
c.2006G>C | p.Gly669Ala | missense_variant | Familial | Maternal | Multiplex | 25363760 | De Rubeis S , et al. (2014) | |
c.2177_2178del | p.Thr726AsnfsTer39 | frameshift_variant | De novo | - | Simplex | 24680889 | Grozeva D , et al. (2014) | |
c.4115C>T | p.Thr1372Ile | missense_variant | Familial | Paternal | Multiplex | 25363760 | De Rubeis S , et al. (2014) | |
c.2177_2178del | p.Thr726AsnfsTer39 | frameshift_variant | Unknown | - | Simplex | 37541188 | Sanchis-Juan A et al. (2023) | |
c.3531_3534del | p.Gly1179AlafsTer10 | frameshift_variant | De novo | - | Simplex | 31981491 | Satterstrom FK et al. (2020) | |
c.3154G>T | p.Gly1052Ter | stop_gained | De novo | - | Unknown | 25533962 | Deciphering Developmental Disorders Study (2014) |
Common Variants
No common variants reported.
SFARI Gene score
High Confidence, Syndromic
Score Delta: Score remained at 1S
criteria met
See SFARI Gene'scoring criteriaWe considered a rigorous statistical comparison between cases and controls, yielding genome-wide statistical significance, with independent replication, to be the strongest possible evidence for a gene. These criteria were relaxed slightly for category 2.
The syndromic category includes mutations that are associated with a substantial degree of increased risk and consistently linked to additional characteristics not required for an ASD diagnosis. If there is independent evidence implicating a gene in idiopathic ASD, it will be listed as "#S" (e.g., 2S, 3S, etc.). If there is no such independent evidence, the gene will be listed simply as "S."
1/1/2021
Score remained at 1
Description
Seven loss-of-function variants in the SETD5 gene, five of which were confirmed as de novo in origin, were identified in affected individuals following screening of 996 individuals with ID in Grozeva et al., 2014; two individuals with de novo LoF SETD5 variants were also identified as autistic in the supplementary material (PMID 24680889). A de novo LoF variant and a de novo likely damaging missense variant in the SETD5 gene were identified in two unrelated ASD probands from 2,270 trios screened by the Autism Sequencing Consortium in De Rubeis et al., 2014 (PMID 25363760); de novo missense variants in SETD5 had previously been observed in ASD probands from simplex families (Neale et al., 2012; Iossifov et al., 2012). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) in this report identified SETD5 as a gene meeting high statistical significance with a 0.05 < FDR 0.1, meaning that this gene had a 90% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). De novo LoF or damaging missense variants in SETD5 have also been identified in multiple individuals with developmental delay, intellectual disability, and/or epilepsy in the absence of ASD (PMIDs 23020937, 25138099, 27334371, 28191889, 28549204). Fernandes et al., 2018 reviewed a total of 42 individuals with SETD5 mutations from 17 publications and determined that ten of these individuals presented with autistic features (23.8%).
10/1/2020
Score remained at 1
Description
Seven loss-of-function variants in the SETD5 gene, five of which were confirmed as de novo in origin, were identified in affected individuals following screening of 996 individuals with ID in Grozeva et al., 2014; two individuals with de novo LoF SETD5 variants were also identified as autistic in the supplementary material (PMID 24680889). A de novo LoF variant and a de novo likely damaging missense variant in the SETD5 gene were identified in two unrelated ASD probands from 2,270 trios screened by the Autism Sequencing Consortium in De Rubeis et al., 2014 (PMID 25363760); de novo missense variants in SETD5 had previously been observed in ASD probands from simplex families (Neale et al., 2012; Iossifov et al., 2012). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) in this report identified SETD5 as a gene meeting high statistical significance with a 0.05 < FDR 0.1, meaning that this gene had a 90% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). De novo LoF or damaging missense variants in SETD5 have also been identified in multiple individuals with developmental delay, intellectual disability, and/or epilepsy in the absence of ASD (PMIDs 23020937, 25138099, 27334371, 28191889, 28549204). Fernandes et al., 2018 reviewed a total of 42 individuals with SETD5 mutations from 17 publications and determined that ten of these individuals presented with autistic features (23.8%).
7/1/2020
Score remained at 1
Description
Seven loss-of-function variants in the SETD5 gene, five of which were confirmed as de novo in origin, were identified in affected individuals following screening of 996 individuals with ID in Grozeva et al., 2014; two individuals with de novo LoF SETD5 variants were also identified as autistic in the supplementary material (PMID 24680889). A de novo LoF variant and a de novo likely damaging missense variant in the SETD5 gene were identified in two unrelated ASD probands from 2,270 trios screened by the Autism Sequencing Consortium in De Rubeis et al., 2014 (PMID 25363760); de novo missense variants in SETD5 had previously been observed in ASD probands from simplex families (Neale et al., 2012; Iossifov et al., 2012). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) in this report identified SETD5 as a gene meeting high statistical significance with a 0.05 < FDR 0.1, meaning that this gene had a 90% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). De novo LoF or damaging missense variants in SETD5 have also been identified in multiple individuals with developmental delay, intellectual disability, and/or epilepsy in the absence of ASD (PMIDs 23020937, 25138099, 27334371, 28191889, 28549204). Fernandes et al., 2018 reviewed a total of 42 individuals with SETD5 mutations from 17 publications and determined that ten of these individuals presented with autistic features (23.8%).
1/1/2020
Score remained at 1
Description
Seven loss-of-function variants in the SETD5 gene, five of which were confirmed as de novo in origin, were identified in affected individuals following screening of 996 individuals with ID in Grozeva et al., 2014; two individuals with de novo LoF SETD5 variants were also identified as autistic in the supplementary material (PMID 24680889). A de novo LoF variant and a de novo likely damaging missense variant in the SETD5 gene were identified in two unrelated ASD probands from 2,270 trios screened by the Autism Sequencing Consortium in De Rubeis et al., 2014 (PMID 25363760); de novo missense variants in SETD5 had previously been observed in ASD probands from simplex families (Neale et al., 2012; Iossifov et al., 2012). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) in this report identified SETD5 as a gene meeting high statistical significance with a 0.05 < FDR 0.1, meaning that this gene had a 90% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). De novo LoF or damaging missense variants in SETD5 have also been identified in multiple individuals with developmental delay, intellectual disability, and/or epilepsy in the absence of ASD (PMIDs 23020937, 25138099, 27334371, 28191889, 28549204). Fernandes et al., 2018 reviewed a total of 42 individuals with SETD5 mutations from 17 publications and determined that ten of these individuals presented with autistic features (23.8%).
10/1/2019
Score remained at 1
New Scoring Scheme
Description
Seven loss-of-function variants in the SETD5 gene, five of which were confirmed as de novo in origin, were identified in affected individuals following screening of 996 individuals with ID in Grozeva et al., 2014; two individuals with de novo LoF SETD5 variants were also identified as autistic in the supplementary material (PMID 24680889). A de novo LoF variant and a de novo likely damaging missense variant in the SETD5 gene were identified in two unrelated ASD probands from 2,270 trios screened by the Autism Sequencing Consortium in De Rubeis et al., 2014 (PMID 25363760); de novo missense variants in SETD5 had previously been observed in ASD probands from simplex families (Neale et al., 2012; Iossifov et al., 2012). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) in this report identified SETD5 as a gene meeting high statistical significance with a 0.05 < FDR 0.1, meaning that this gene had a 90% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). De novo LoF or damaging missense variants in SETD5 have also been identified in multiple individuals with developmental delay, intellectual disability, and/or epilepsy in the absence of ASD (PMIDs 23020937, 25138099, 27334371, 28191889, 28549204). Fernandes et al., 2018 reviewed a total of 42 individuals with SETD5 mutations from 17 publications and determined that ten of these individuals presented with autistic features (23.8%).
10/1/2018
Score remained at 1S
Description
Seven loss-of-function variants in the SETD5 gene, five of which were confirmed as de novo in origin, were identified in affected individuals following screening of 996 individuals with ID in Grozeva et al., 2014; two individuals with de novo LoF SETD5 variants were also identified as autistic in the supplementary material (PMID 24680889). A de novo LoF variant and a de novo likely damaging missense variant in the SETD5 gene were identified in two unrelated ASD probands from 2,270 trios screened by the Autism Sequencing Consortium in De Rubeis et al., 2014 (PMID 25363760); de novo missense variants in SETD5 had previously been observed in ASD probands from simplex families (Neale et al., 2012; Iossifov et al., 2012). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) in this report identified SETD5 as a gene meeting high statistical significance with a 0.05 < FDR 0.1, meaning that this gene had a 90% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). De novo LoF or damaging missense variants in SETD5 have also been identified in multiple individuals with developmental delay, intellectual disability, and/or epilepsy in the absence of ASD (PMIDs 23020937, 25138099, 27334371, 28191889, 28549204). Fernandes et al., 2018 reviewed a total of 42 individuals with SETD5 mutations from 17 publications and determined that ten of these individuals presented with autistic features (23.8%).
10/1/2017
Score remained at 1S
Description
Seven loss-of-function variants in the SETD5 gene, five of which were confirmed as de novo in origin, were identified in affected individuals following screening of 996 individuals with ID in Grozeva et al., 2014; two individuals with de novo LoF SETD5 variants were also identified as âautisticâ in the supplementary material (PMID 24680889). A de novo LoF variant and a de novo likely damaging missense variant in the SETD5 gene were identified in two unrelated ASD probands from 2,270 trios screened by the Autism Sequencing Consortium in De Rubeis et al., 2014 (PMID 25363760); de novo missense variants in SETD5 had previously been observed in ASD probands from simplex families (Neale et al., 2012; Iossifov et al., 2012). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) in this report identified SETD5 as a gene meeting high statistical significance with a 0.05 < FDR ? 0.1, meaning that this gene had a ? 90% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). De novo LoF or damaging missense variants in SETD5 have also been identified in multiple individuals with developmental delay, intellectual disability, and/or epilepsy in the absence of ASD (PMIDs 23020937, 25138099, 27334371, 28191889, 28549204).
Reports Added
[Expansion and further delineation of the SETD5 phenotype leading to global developmental delay, variable dysmorphic features, and reduced penetrance.2017] [Expanding the genetic heterogeneity of intellectual disability.2017] [Exome sequencing reveals NAA15 and PUF60 as candidate genes associated with intellectual disability.2017] [Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands.2017] [Exome Pool-Seq in neurodevelopmental disorders.2017]4/1/2017
Score remained at 1S
Description
Seven loss-of-function variants in the SETD5 gene, five of which were confirmed as de novo in origin, were identified in affected individuals following screening of 996 individuals with ID; two individuals with de novo LoF SETD5 variants were also identified as âautisticâ in the supplementary material (PMID 24680889). A de novo LoF variant and a de novo likely damaging missense variant in the SETD5 gene were identified in two unrelated ASD probands from 2,270 trios screened by the Autism Sequencing Consortium (PMID 25363760). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified SETD5 as a gene meeting high statistical significance with a 0.05< FDR ?0.1, meaning that this gene had a ?90% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
Reports Added
[Patterns and rates of exonic de novo mutations in autism spectrum disorders.2012] [De novo gene disruptions in children on the autistic spectrum.2012] [Convergence of genes and cellular pathways dysregulated in autism spectrum disorders.2014] [Synaptic, transcriptional and chromatin genes disrupted in autism.2014] [Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study.2012] [Deletion of 3p25.3 in a patient with intellectual disability and dysmorphic features with further definition of a critical region.2013] [De novo loss-of-function mutations in SETD5, encoding a methyltransferase in a 3p25 microdeletion syndrome critical region, cause intellectual disa...2014] [Loss-of-function variants of SETD5 cause intellectual disability and the core phenotype of microdeletion 3p25.3 syndrome.2014] [Large-scale discovery of novel genetic causes of developmental disorders.2014] [Low load for disruptive mutations in autism genes and their biased transmission.2015] [Mutations in HECW2 are associated with intellectual disability and epilepsy.2016] [Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnose...2016] [SETD5 loss-of-function mutation as a likely cause of a familial syndromic intellectual disability with variable phenotypic expression.2016] [De novo genic mutations among a Chinese autism spectrum disorder cohort.2016] [Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases.2017] [SETD5 gene variant associated with mild intellectual disability - a case report.2017]1/1/2017
Score remained at 1S
Description
Seven loss-of-function variants in the SETD5 gene, five of which were confirmed as de novo in origin, were identified in affected individuals following screening of 996 individuals with ID; two individuals with de novo LoF SETD5 variants were also identified as âautisticâ in the supplementary material (PMID 24680889). A de novo LoF variant and a de novo likely damaging missense variant in the SETD5 gene were identified in two unrelated ASD probands from 2,270 trios screened by the Autism Sequencing Consortium (PMID 25363760). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified SETD5 as a gene meeting high statistical significance with a 0.05 < FDR ?0.1, meaning that this gene had a ?90% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
10/1/2016
Score remained at 1S
Description
Seven loss-of-function variants in the SETD5 gene, five of which were confirmed as de novo in origin, were identified in affected individuals following screening of 996 individuals with ID; two individuals with de novo LoF SETD5 variants were also identified as âautisticâ in the supplementary material (PMID 24680889). A de novo LoF variant and a de novo likely damaging missense variant in the SETD5 gene were identified in two unrelated ASD probands from 2,270 trios screened by the Autism Sequencing Consortium (PMID 25363760). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified SETD5 as a gene meeting high statistical significance with a 0.05
7/1/2016
Score remained at 1S
Description
Seven loss-of-function variants in the SETD5 gene, five of which were confirmed as de novo in origin, were identified in affected individuals following screening of 996 individuals with ID; two individuals with de novo LoF SETD5 variants were also identified as âautisticâ in the supplementary material (PMID 24680889). A de novo LoF variant and a de novo likely damaging missense variant in the SETD5 gene were identified in two unrelated ASD probands from 2,270 trios screened by the Autism Sequencing Consortium (PMID 25363760). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified SETD5 as a gene meeting high statistical significance with a 0.05
Reports Added
[Mutations in HECW2 are associated with intellectual disability and epilepsy.2016] [Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnose...2016] [SETD5 loss-of-function mutation as a likely cause of a familial syndromic intellectual disability with variable phenotypic expression.2016]1/1/2016
Score remained at 1S
Description
Seven loss-of-function variants in the SETD5 gene, five of which were confirmed as de novo in origin, were identified in affected individuals following screening of 996 individuals with ID; two individuals with de novo LoF SETD5 variants were also identified as âautisticâ in the supplementary material (PMID 24680889). A de novo LoF variant and a de novo likely damaging missense variant in the SETD5 gene were identified in two unrelated ASD probands from 2,270 trios screened by the Autism Sequencing Consortium (PMID 25363760). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified SETD5 as a gene meeting high statistical significance with a 0.05
Reports Added
[Patterns and rates of exonic de novo mutations in autism spectrum disorders.2012] [De novo gene disruptions in children on the autistic spectrum.2012] [Convergence of genes and cellular pathways dysregulated in autism spectrum disorders.2014] [Synaptic, transcriptional and chromatin genes disrupted in autism.2014] [Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study.2012] [Deletion of 3p25.3 in a patient with intellectual disability and dysmorphic features with further definition of a critical region.2013] [De novo loss-of-function mutations in SETD5, encoding a methyltransferase in a 3p25 microdeletion syndrome critical region, cause intellectual disa...2014] [Loss-of-function variants of SETD5 cause intellectual disability and the core phenotype of microdeletion 3p25.3 syndrome.2014] [Large-scale discovery of novel genetic causes of developmental disorders.2014] [Low load for disruptive mutations in autism genes and their biased transmission.2015]1/1/2015
Score remained at 1S
Description
Seven loss-of-function variants in the SETD5 gene, five of which were confirmed as de novo in origin, were identified in affected individuals following screening of 996 individuals with ID; two individuals with de novo LoF SETD5 variants were also identified as âautisticâ in the supplementary material (PMID 24680889). A de novo LoF variant and a de novo likely damaging missense variant in the SETD5 gene were identified in two unrelated ASD probands from 2,270 trios screened by the Autism Sequencing Consortium (PMID 25363760). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified SETD5 as a gene meeting high statistical significance with a 0.05
10/1/2014
Decreased from 3S to 1S
Description
Seven loss-of-function variants in the SETD5 gene, five of which were confirmed as de novo in origin, were identified in affected individuals following screening of 996 individuals with ID; two individuals with de novo LoF SETD5 variants were also identified as âautisticâ in the supplementary material (PMID 24680889). A de novo LoF variant and a de novo likely damaging missense variant in the SETD5 gene were identified in two unrelated ASD probands from 2,270 trios screened by the Autism Sequencing Consortium (PMID 25363760). Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified SETD5 as a gene meeting high statistical significance with a 0.05
7/1/2014
Increased from No data to 3S
Description
Seven loss-of-function variants in the SETD5 gene, five of which were confirmed as de novo in origin, were identified in affected individuals following screening of 996 individuals with ID; two individuals with de novo LoF SETD5 variants were also identified as âautisticâ in the supplementary material (PMID 24680889).
4/1/2014
Increased from No data to 3S
Description
Seven loss-of-function variants in the SETD5 gene, five of which were confirmed as de novo in origin, were identified in affected individuals following screening of 996 individuals with ID; two individuals with de novo LoF SETD5 variants were also identified as âautisticâ in the supplementary material (PMID 24680889).
Krishnan Probability Score
Score 0.49387519752768
Ranking 3940/25841 scored genes
[Show Scoring Methodology]
ExAC Score
Score 0.99999956377817
Ranking 259/18225 scored genes
[Show Scoring Methodology]
Iossifov Probability Score
Score 0.903
Ranking 136/239 scored genes
[Show Scoring Methodology]
Sanders TADA Score
Score 0.0025046092460738
Ranking 22/18665 scored genes
[Show Scoring Methodology]
Larsen Cumulative Evidence Score
Score 62
Ranking 26/461 scored genes
[Show Scoring Methodology]
Zhang D Score
Score -0.063610089782681
Ranking 10921/20870 scored genes
[Show Scoring Methodology]
Interactome
- Protein Binding
- DNA Binding
- RNA Binding
- Protein Modification
- Direct Regulation
- ASD-Linked Genes
Interaction Table
Interactor Symbol | Interactor Name | Interactor Organism | Interactor Type | Entrez ID | Uniprot ID |
---|---|---|---|---|---|
CEP70 | centrosomal protein 70kDa | Human | Protein Binding | 80321 | Q8NHQ1 |
DPPA2 | Developmental pluripotency-associated protein 2 | Human | Protein Binding | 151871 | Q7Z7J5 |
miR126-5p | microRNA 126 | Human | RNA Binding | 406913 | N/A |
miR1265p | microRNA 126 | Human | RNA Binding | 406913 | N/A |
PRR20E | Proline-rich protein 20E | Human | Protein Binding | 122183 | P86478 |